AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
136
Employees136
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
136
Employees136

ANAB Key Statistics

Market cap
547.90M
Market cap547.90M
Price-Earnings ratio
-4.50
Price-Earnings ratio-4.50
Dividend yield
Dividend yield
Average volume
519.61K
Average volume519.61K
High today
$20.74
High today$20.74
Low today
$17.11
Low today$17.11
Open price
$20.16
Open price$20.16
Volume
889.07K
Volume889.07K
52 Week high
$40.55
52 Week high$40.55
52 Week low
$12.21
52 Week low$12.21

ANAB News

Simply Wall St 7h
AnaptysBio Sees Insider Stock Selling

Viewing insider transactions for AnaptysBio, Inc.'s ( ) over the last year, we see that insiders were net sellers. This means that a larger number of shares wer...

AnaptysBio Sees Insider Stock Selling

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.